{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-037681","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.592685+00:00","generated_at":"2026-06-12T15:33:01.206346+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.0,"calibrated_materiality_score":0.0,"confidence":"low","headline":"Eterna Therapeutics posts August 2023 investor presentation; no material news disclosed","bullets":["Item 7.01 furnished new investor presentation (Exhibit 99.1) with no specific financial results or corporate events.","Presentation available on company website; filing does not contain earnings, guidance, or operational updates.","No material changes, transactions, or forward-looking statements identified in the furnished exhibit.","Routine disclosure intended to update investor materials without new material information."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-037681","json":"https://secwatch.observer/filing/0001140361-23-037681.json","markdown":"https://secwatch.observer/filing/0001140361-23-037681.md","text":"https://secwatch.observer/filing/0001140361-23-037681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000114036123037681/0001140361-23-037681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000114036123037681/brhc20056925_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T15:33:01.206346+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}